Actemra: first IL-6 receptor inhibitor for RA; BuTrans: first once-weekly transdermal opioid; Onsolis: opioid buccal film for breakthrough cancer pain; Victoza: first GLP-1 analogue for type 2 diabetes
Progress in stroke research and clinical care in Canada over the last decade produced the need for a specifically Canadian conference on the condition.